Cargando…

Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists

Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are dynamic cells that can sense the environment, adapting their regulatory functions to different conditions. Accordingly, the therapeutic potential of BM-MSCs can be modulated by preconditioning strategies aimed at modifying their paracrine a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evaristo-Mendonça, Fabiana, Sardella-Silva, Gabriela, Kasai-Brunswick, Tais Hanae, Campos, Raquel Maria Pereira, Domizi, Pablo, Santiago, Marcelo Felippe, de Melo Reis, Ricardo Augusto, Mendez-Otero, Rosalia, Ribeiro-Resende, Victor Túlio, Pimentel-Coelho, Pedro Moreno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721436/ https://www.ncbi.nlm.nih.gov/pubmed/31531025 http://dx.doi.org/10.1155/2019/7692973

Ejemplares similares

Erratum to “Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists”
por: Evaristo-Mendonça, Fabiana, et al.
Publicado: (2020)

Stem cell therapies in cardiac diseases: Current status and future possibilities
por: Kasai-Brunswick, Tais Hanae, et al.
Publicado: (2021)

Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials
por: José, Vitória Santório de São, et al.
Publicado: (2017)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury
por: Escalhão, Cláudia Cardoso Maciel, et al.
Publicado: (2017)

Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells
por: Coelho de Oliveira, Vanessa Carvalho, et al.
Publicado: (2017)

Biological behavior of mesenchymal stem cells on poly-ε-caprolactone filaments and a strategy for tissue engineering of segments of the peripheral nerves
por: Carrier-Ruiz, A., et al.
Publicado: (2015)

Intrinsic Angiogenic Potential and Migration Capacity of Human Mesenchymal Stromal Cells Derived from Menstrual Blood and Bone Marrow
por: Santos, Rosana de Almeida, et al.
Publicado: (2020)

Cell-Based Therapies for Heart Failure
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2021)

Editorial: New Insights into the Pathophysiology and Treatment of Neonatal Hypoxic–Ischemic Encephalopathy
por: Rosado-de-Castro, Paulo Henrique, et al.
Publicado: (2016)

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning
por: Nelson, Michelle H., et al.
Publicado: (2016)

Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome
por: Cheng, Hui-Yun, et al.
Publicado: (2021)

Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system
por: Ribeiro-Resende, Victor Tulio, et al.
Publicado: (2012)

Anti-Inflammatory Preconditioning by Agonists of Adenosine A1 Receptor
por: Nakav, Sigal, et al.
Publicado: (2008)

Four Seasons for Schwann Cell Biology, Revisiting Key Periods: Development, Homeostasis, Repair, and Aging
por: Sardella-Silva, Gabriela, et al.
Publicado: (2021)

Hyperacute transplantation of umbilical cord mesenchymal stromal cells in a model of severe intracerebral hemorrhage
por: Mello, Tanira Giara, et al.
Publicado: (2022)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment
por: Wang, Peng-Fei, et al.
Publicado: (2015)

Argon preconditioning protects neuronal cells with a Toll-like receptor-mediated effect
por: Scheid, Stefanie, et al.
Publicado: (2022)

Hypoxic preconditioning enhances mesenchymal stromal cell lung repair capacity
por: Cruz, Fernanda Ferreira, et al.
Publicado: (2015)

Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells
por: Rodriguez, Luis A., et al.
Publicado: (2019)

Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
por: Silva dos Santos, Danúbia, et al.
Publicado: (2023)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

Chromosomal aberrations after induced pluripotent stem cells reprogramming
por: Vaz, Isadora May, et al.
Publicado: (2021)

Preconditioning and parallel preconditioning
por: Duff, I S, et al.
Publicado: (1998)

Development and Application of Nanoparticles in Biomedical Imaging
por: Rosado-de-Castro, Paulo H., et al.
Publicado: (2018)

Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties
por: Schepici, Giovanni, et al.
Publicado: (2022)

Preconditioned Mesenchymal Stromal Cell-Derived Extracellular Vesicles (EVs) Counteract Inflammaging
por: Gorgun, Cansu, et al.
Publicado: (2022)

Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
por: Roodveldt, Cintia, et al.
Publicado: (2013)

Continuing Effect of Cytokines and Toll-Like Receptor Agonists on Indoleamine-2,3-Dioxygenase-1 in Human Periodontal Ligament Stem/Stromal Cells
por: Behm, Christian, et al.
Publicado: (2020)

Toll-Like Receptors and Dental Mesenchymal Stromal Cells
por: Andrukhov, Oleh
Publicado: (2021)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Patient-derived osteosarcoma cells are resistant to methotrexate
por: dos Santos Cavalcanti, Amanda, et al.
Publicado: (2017)

Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage
por: Rosado-de-Castro, Paulo Henrique, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6rjv03d54t5v27eih1tqoqcjik